ID   APAF_RAT                Reviewed;        1249 AA.
AC   Q9EPV5;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   29-MAY-2024, entry version 164.
DE   RecName: Full=Apoptotic protease-activating factor 1;
DE            Short=APAF-1;
GN   Name=Apaf1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Itoh T., Itoh A., Pleasure D.;
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   DEVELOPMENTAL STAGE, AND INDUCTION BY BRAIN INJURY.
RX   PubMed=11567033; DOI=10.1523/jneurosci.21-19-07439.2001;
RA   Yakovlev A.G., Ota K., Wang G., Movsesyan V., Bao W.-L., Yoshihara K.,
RA   Faden A.I.;
RT   "Differential expression of apoptotic protease-activating factor-1 and
RT   caspase-3 genes and susceptibility to apoptosis during brain development
RT   and after traumatic brain injury.";
RL   J. Neurosci. 21:7439-7446(2001).
CC   -!- FUNCTION: Regulates programmed cell death; necessary for normal brain
CC       development. Participates with pro-caspase-9 (Apaf-3) in the cytochrome
CC       c-dependent activation of caspase-3, leading to apoptosis. This
CC       activation requires ATP (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Monomer. Oligomerizes to a heptameric ring, known as the
CC       apoptosome, upon binding of cytochrome c and dATP. Oligomeric Apaf-1
CC       and pro-caspase-9 bind to each other via their respective NH2-terminal
CC       CARD domains. Interacts with UACA. Interacts with APIP (By similarity).
CC       Interacts (via CARD and NACHT domains) with NAIP/BIRC1 (via NACHT
CC       domain) (By similarity). Interacts with CIAO2A (By similarity).
CC       {ECO:0000250|UniProtKB:O14727}.
CC   -!- INTERACTION:
CC       Q9EPV5; O00291: HIP1; Xeno; NbExp=2; IntAct=EBI-6978501, EBI-473886;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in brain cortex in embryos (17
CC       dpc) and newborn rats up to P7. Very low expression thereafter.
CC       {ECO:0000269|PubMed:11567033}.
CC   -!- INDUCTION: By brain injury. {ECO:0000269|PubMed:11567033}.
CC   -!- DOMAIN: The CARD domain mediates interaction with APIP.
CC   -!- DOMAIN: The monomeric form is autoinhibited in a closed conformation
CC       through a bound ADP at the nucleotide binding site. Exchange of ADP for
CC       ATP and binding of cytochrome c trigger a large conformational change
CC       where the first WD repeat region swings out, allowing the NB-ARC domain
CC       to rotate and expose the contact areas for oligomerization (By
CC       similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: Physiological concentrations of calcium ions negatively
CC       affect the assembly of apoptosome by inhibiting nucleotide exchange in
CC       the monomeric form. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF320222; AAG35067.1; -; mRNA.
DR   RefSeq; NP_076469.1; NM_023979.1.
DR   AlphaFoldDB; Q9EPV5; -.
DR   SMR; Q9EPV5; -.
DR   IntAct; Q9EPV5; 2.
DR   MINT; Q9EPV5; -.
DR   STRING; 10116.ENSRNOP00000010869; -.
DR   iPTMnet; Q9EPV5; -.
DR   PhosphoSitePlus; Q9EPV5; -.
DR   jPOST; Q9EPV5; -.
DR   PaxDb; 10116-ENSRNOP00000010869; -.
DR   Ensembl; ENSRNOT00000010869.7; ENSRNOP00000010869.6; ENSRNOG00000008022.7.
DR   Ensembl; ENSRNOT00055035561; ENSRNOP00055028841; ENSRNOG00055020818.
DR   Ensembl; ENSRNOT00060036631; ENSRNOP00060030147; ENSRNOG00060021116.
DR   Ensembl; ENSRNOT00065039243; ENSRNOP00065031879; ENSRNOG00065022947.
DR   GeneID; 78963; -.
DR   KEGG; rno:78963; -.
DR   UCSC; RGD:620575; rat.
DR   AGR; RGD:620575; -.
DR   CTD; 317; -.
DR   RGD; 620575; Apaf1.
DR   eggNOG; KOG4155; Eukaryota.
DR   eggNOG; KOG4658; Eukaryota.
DR   GeneTree; ENSGT00940000157710; -.
DR   HOGENOM; CLU_005071_1_0_1; -.
DR   InParanoid; Q9EPV5; -.
DR   OMA; YHMANAN; -.
DR   OrthoDB; 2995530at2759; -.
DR   PhylomeDB; Q9EPV5; -.
DR   Reactome; R-RNO-111458; Formation of apoptosome.
DR   Reactome; R-RNO-111459; Activation of caspases through apoptosome-mediated cleavage.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-9627069; Regulation of the apoptosome activity.
DR   PRO; PR:Q9EPV5; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000008022; Expressed in jejunum and 19 other cell types or tissues.
DR   GO; GO:0043293; C:apoptosome; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0043531; F:ADP binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; ISO:RGD.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:0010659; P:cardiac muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:RGD.
DR   GO; GO:0030900; P:forebrain development; ISO:RGD.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISO:RGD.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0001843; P:neural tube closure; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:1902510; P:regulation of apoptotic DNA fragmentation; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   CDD; cd08323; CARD_APAF1; 1.
DR   CDD; cd00200; WD40; 2.
DR   Gene3D; 1.25.40.370; -; 1.
DR   Gene3D; 1.10.533.10; Death Domain, Fas; 1.
DR   Gene3D; 1.10.8.430; Helical domain of apoptotic protease-activating factors; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 2.
DR   InterPro; IPR017251; Apaf-1.
DR   InterPro; IPR041452; APAF1_C.
DR   InterPro; IPR037963; APAF1_CARD_dom.
DR   InterPro; IPR048975; APAF1_WHD.
DR   InterPro; IPR042197; Apaf_helical.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR002182; NB-ARC.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   InterPro; IPR001680; WD40_rpt.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   PANTHER; PTHR22845; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; 1.
DR   PANTHER; PTHR22845:SF5; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; 1.
DR   Pfam; PF21296; APAF-1-like_WHD; 1.
DR   Pfam; PF17908; APAF1_C; 1.
DR   Pfam; PF00619; CARD; 1.
DR   Pfam; PF00931; NB-ARC; 1.
DR   Pfam; PF00400; WD40; 10.
DR   PIRSF; PIRSF037646; Apop_pept_activating-1; 1.
DR   PRINTS; PR00364; DISEASERSIST.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00320; WD40; 13.
DR   SUPFAM; SSF47986; DEATH domain; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF50978; WD40 repeat-like; 2.
DR   PROSITE; PS50209; CARD; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 4.
DR   PROSITE; PS50082; WD_REPEATS_2; 9.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; ATP-binding; Calcium; Cytoplasm; Nucleotide-binding;
KW   Reference proteome; Repeat; WD repeat.
FT   CHAIN           1..1249
FT                   /note="Apoptotic protease-activating factor 1"
FT                   /id="PRO_0000050846"
FT   DOMAIN          1..90
FT                   /note="CARD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00046"
FT   DOMAIN          106..415
FT                   /note="NB-ARC"
FT   REPEAT          613..652
FT                   /note="WD 1-1"
FT   REPEAT          655..694
FT                   /note="WD 1-2"
FT   REPEAT          697..738
FT                   /note="WD 1-3"
FT   REPEAT          741..780
FT                   /note="WD 1-4"
FT   REPEAT          796..837
FT                   /note="WD 1-5"
FT   REPEAT          838..877
FT                   /note="WD 1-6"
FT   REPEAT          880..910
FT                   /note="WD 1-7"
FT   REPEAT          922..958
FT                   /note="WD 2-1"
FT   REPEAT          959..998
FT                   /note="WD 2-2"
FT   REPEAT          1001..1040
FT                   /note="WD 2-3"
FT   REPEAT          1042..1080
FT                   /note="WD 2-4"
FT   REPEAT          1083..1122
FT                   /note="WD 2-5"
FT   REPEAT          1125..1164
FT                   /note="WD 2-6"
FT   REPEAT          1176..1213
FT                   /note="WD 2-7"
FT   REPEAT          1214..1249
FT                   /note="WD 2-8"
FT   REGION          910..921
FT                   /note="Interpropeller linker"
FT                   /evidence="ECO:0000250"
FT   BINDING         154..161
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   BINDING         265
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   1249 AA;  141152 MW;  7B4A8116FAD008E9 CRC64;
     MDAKARNCLL QHKEALEKDI KTSYIMDHMI SNGVLTVVEE EKVKSQATQY QRAAALIKMI
     LNKDNYAYIS FYNALLHEGY KDLAGLLHSG LPLVSSSSGK DTDGGNTSFV RTVLCEGGVP
     QRPVIFVTRK KLVSAIQQKL WKLNGEPGWV TIYGMAGCGK SVLAAEAVRD HALLEGCFSG
     GVHWVSIGKQ DKSGLLMKLQ NLCTRLGQEE SFSQRLPLNI EEAKDRLRVL MLRKHPRSLL
     ILDDVWDPWV LKAFDNQCQI LLTTRDKSVT DSVMGPKYVI PVESGLGKEK GLEILSLFVN
     MKKEDLPVEA HSIIKECKGS PLVVSLVGAL LRDFPNRWAY YLRQLQNKQF KRIRKSSSYD
     YEALDEAMSI SVEMLREDIK DYYTDLSILQ KDVKVPTKVL CVLWDLETEE VEDILQEFVN
     KSLLFCNRNG KSFCYYLHDL QVDFLTEKNR SQLQDLHRKM VTQFQRYHQP HTLSPGQEDC
     MYWYNFLAYH MASAGMHKEL CALMFSLDWI KAKTELVGPA HLIHEFVEYR HILDEKDCAV
     CENFQEFLSL NGHLLGRQPF PNIVQLGLCE PETSEVYQQA KLQAKQEVDT GRLYLEWINK
     KTIKNLSRLV VRPHTDAVYH ACFSQDGQRI ASCGADKTLQ VFKAETGEKL LDIKAHEDEV
     LCCAFSSDDS YIATCSVDKK VKIWDSGTGK LVHTYEEHSE QVNCCHFTNK SNHLLLATGS
     NDSFLKLWDL NQKECRNTMF GHTNSVTHCR FSPDDELLAS CSADGTLKLW DVRSANEKKS
     INVKRFFLSS EDPPEDVEVI VKCCSWSADG DRIIVAAKNK VLLLDIHTSG LLTEIHTGHH
     STIQYCDFSP YDHLAVIALS QYCVELWNID SRVKVADCRG HLSWVHGVMF SPDGSSFLTA
     SDDQTIRVWE TRKVCKNSAI VLKQEIDVVF QENEMMVLAV DNIRGLQLIA GKTGQIDYLP
     EAQVSCCCLS PHLEYVAFGD EEGAIKIIEL PNNRVFSSGI GHKKAVRHIQ FTADGKTLIS
     SSEDSVIQVW NWQTEEYVFL QAHQETVKDF RLLRDSRLLS WSFDGTVKVW NVITGRIERD
     FTCHQGTVLS CAISSDATKF SSTSADKTAK IWSFELPSPL HELKGHNSCV RCSAFSLDGI
     LLATGDDNGE IRIWNVSDGQ LLHLCAPISI EEGTATHGGW VTDVCFSPDR KMLVSAGGYL
     KWWNVVTGES SQTFYTNGTN LKKIHVSPDF RTYVTVDNLG ILYILQVLE
//
